Cargando…
Risk factors and outcome of Chimeric Antigen Receptor T-Cell patients admitted to Pediatric Intensive Care Unit: CART-PICU study
INTRODUCTION: Chimeric antigen receptor (CAR)T-cell CD19 therapy is an effective treatment for relapsed/refractory B-cell acute lymphoblastic leukemia. It can be associated with life-threatening toxicities which often require PICU admission. Purpose: to describe clinical characteristics, treatment a...
Autores principales: | Caballero-Bellón, Marina, Alonso-Saladrigues, Anna, Bobillo-Perez, Sara, Faura, Anna, Arqués, Laura, Rivera, Cristina, Català, Albert, Dapena, Jose Luis, Rives, Susana, Jordan, Iolanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433898/ https://www.ncbi.nlm.nih.gov/pubmed/37600775 http://dx.doi.org/10.3389/fimmu.2023.1219289 |
Ejemplares similares
-
Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia
por: Deyà-Martínez, A., et al.
Publicado: (2020) -
Outcome in Children Admitted to the First PICU in Malawi*
por: de Visser, Mirjam A., et al.
Publicado: (2023) -
Factors associated with the clinical outcome of patients with relapsed/refractory CD19(+) acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
por: Ortiz-Maldonado, Valentín, et al.
Publicado: (2021) -
Outcomes of Children With Firearm Injuries Admitted to the PICU in the United States*
por: Bagdure, Dayanand, et al.
Publicado: (2021) -
Clinical Features and Outcomes of Children Admitted to the PICU due to Rotavirus Infection
por: Gün, Emrah, et al.
Publicado: (2021)